Urtoxazumab

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameUrtoxazumab
Drug Alias NameAnti-verotoxin of O-157TMA-15
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionShiga toxin inhibitors
TargetsShiga toxin
Therapy Area/IndicationsHemolytic-Uremic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTeijin Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeijin Pharma Ltd
Active IndicationsN/A
Inactive IndicationsHemolytic-Uremic Syndrome

Other Information

ATC CodeN/A
Related LinksWikipedia